Abbott sues J&J Ahead of golimumab launch
06 May 2009
Nancy Faigen
Abbott Laboratories has sued
Centocor Ortho Biotech (part of
Johnson & Johnson) for patent infringement in anticipation of what it says is "an imminent US launch" of Centocor's next-generation, human anti-TNF monoclonal antibody golimumab (Simponi). Abbott markets the human anti-TNF...
Please Login to read the full article.